Developer docs
API playgroundTry for free, no card

Search company profiles

Pentagrit Discovery

Full company profile

uuid0031rof

Namestring
Pentagrit Discovery
Legal namestring
Pentagrit
Websiteurl
pentagrit.com
Company typeenum
Private
Founded yearint
2011
Short descriptiontext

Pentagrit Discovery is an India-based zebrafish CRO providing preclinical drug discovery and toxicology services, including target validation, PK/biodistribution, efficacy screening, and AI-assisted histology, to pharmaceutical, biotechnology, and agrochemical clients globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersChennai, India
HQ citystring
Chennai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
preclinical drug discovery, zebrafish CRO services, contract research organization, pharmacology models, toxicology screening
Industry6 codes
PRIMARYHLAGAFAA
In Vivo Pharmacology (Efficacy/PD Models)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAAAIAK
In Vivo Discovery & Translational Models Platforms (humanized models, PK/PD, efficacy)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAIAI
Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAIAE
AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGAFAC
DMPK / ADME & Bioanalysis
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAIALAA
Drug Discovery (Target ID/Validation & Hit Discovery)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Preclinical Contract Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research Services
TypeProfessional Services
Description

Project-based preclinical research contracts providing zebrafish-based drug discovery, efficacy screening, PK/biodistribution studies, and toxicology assessment services to pharmaceutical and biotech companies

pentagrit.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Pentagrit Discovery is a Contract Research Organization providing zebrafish-based preclinical drug discovery services to pharmaceutical, biotechnology, and agrochemical clients. The company delivers target engagement validation, PK/biodistribution studies, efficacy screening, phenotype rescue behavioral assays, AI-integrated machine interface systems, and a broad disease model library across neuro, metabolic, muscular, rare, eye, inflammation, and tumor indications. Toxicology services cover acute, chronic, reproductive, developmental, behavioral, and organ-specific assessments, with 140+ studies delivered annually on a 60-day standard turnaround.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 60-day study turnaround time
+3 more records
Product overview1 text field

Pentagrit Discovery is a Zebrafish CRO (Contract Research Organization) offering a comprehensive platform of drug discovery services using zebrafish as the primary research model. The company provides an integrated portfolio including Target Engagement (knock-out lines), PK/Biodistribution (DMPK Services), Efficacy Screening, Phenotype Rescue (Behaviour Assays), Agro Discovery, Machine Interface (Zebrafish AI Systems), and characterized Zebrafish Strains. Their discovery platforms cover specific therapeutic areas including MASH, Obesity, NF1, CART, and SSRI screening. The company also maintains extensive disease model libraries spanning Neurodegeneration, Metabolic, Muscular, Rare, Eye, Inflammation, and Tumor categories. Toxicology services include Acute/Chronic, Reproductive, Developmental, Behavioral, and Organ-Specific Toxicity testing. All services leverage zebrafish genetic variants with AI-powered analysis of full functional physiology.

Product and service1 record
1Target Engagement (Knock-Out Lines)
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1AD Instruments
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-08
Description

Pentagrit adopted the Powerlab Software System from AD Instruments for real-time data acquisition and analysis in neuronal circuitry research. This integration enhances early discovery services in neurology and deep learning capabilities for AI and technology domains.

pentagrit.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global drug discovery and development CRO with end-to-end preclinical and clinical capabilities. Competes broadly with Pentagrit for outsourced discovery work, though zebrafish is one of many platforms rather than its core focus.

TypeBroad incumbent
Description

Global CRO/CDMO providing preclinical research, DMPK, toxicology, and discovery services. Overlaps with Pentagrit in outsourced preclinical offerings to pharma, at much larger scale and broader service breadth.

TypeBroad incumbent
Description

Preclinical CRO and research models provider with toxicology, safety, and discovery services including alternative model organisms. Competes with Pentagrit for outsourced preclinical work but at significantly larger scale and broader scope.

TypeDirect peer
Description

European zebrafish CRO offering preclinical drug discovery and toxicology services. Directly comparable to Pentagrit in model organism (zebrafish), service mix (efficacy, safety, target validation), and B2B CRO delivery to pharma and biotech clients.

TypeDirect peer
Description

Global preclinical CRO with established zebrafish and translational oncology platforms. Comparable in providing zebrafish-based in vivo pharmacology services to pharma and biotech, with broader therapeutic area coverage.

6Hunter Biotechnology
TypeDirect peer
Description

China-based zebrafish CRO specializing in preclinical drug safety and efficacy evaluation under OECD/GLP standards. Direct competitor to Pentagrit with overlapping zebrafish toxicology and efficacy screening offerings for global pharma sponsors.

TypeBroad incumbent
Description

Large-scale preclinical CRO offering safety assessment, DMPK, and discovery services globally. Broader portfolio than Pentagrit with significant zebrafish and alternative model capabilities, but specializes across many non-zebrafish modalities.

TypeBroad incumbent
Description

Global life sciences testing CRO offering preclinical, discovery, and central laboratory services. Competes for outsourced preclinical study contracts from pharma, though zebrafish is one of many alternative model offerings.

TypeRegional player
Description

India-based CRO providing drug discovery and development services across multiple therapeutic areas. Same geographic base as Pentagrit and overlapping preclinical CRO customer segments, with broader integrated discovery-to-development offering.

10Syngene International
TypeRegional player
Description

India-headquartered integrated CRO/CDMO offering discovery, development, and manufacturing services. Same geographic base as Pentagrit and overlapping preclinical CRO customer base, though broader therapeutic and modality coverage.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights1 record

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pentagrit Discovery

Preclinical Contract Research Servicespentagrit.com

Pentagrit Discovery is an India-based zebrafish CRO providing preclinical drug discovery and toxicology services, including target validation, PK/biodistribution, efficacy screening, and AI-assisted histology, to pharmaceutical, biotechnology, and agrochemical clients globally.

Pentagrit Discovery firmographics

Firmographics
Name
Pentagrit Discovery
Legal name
Pentagrit
Website
https://pentagrit.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Pentagrit Discovery is an India-based zebrafish CRO providing preclinical drug discovery and toxicology services, including target validation, PK/biodistribution, efficacy screening, and AI-assisted histology, to pharmaceutical, biotechnology, and agrochemical clients globally.
Ownership category
akta.pro rank

Pentagrit Discovery industry classification

Industry
Product category
Preclinical Contract Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAFAA
In Vivo Pharmacology (Efficacy/PD Models)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAAAIAK
In Vivo Discovery & Translational Models Platforms (humanized models, PK/PD, efficacy)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAIAI
Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAIAE
AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGAFAC
DMPK / ADME & Bioanalysis
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAIALAA
Drug Discovery (Target ID/Validation & Hit Discovery)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development

Keywords

  • Preclinical drug discovery
  • Zebrafish CRO services
  • Contract research organization
  • Pharmacology models
  • Toxicology screening

Where Pentagrit Discovery is headquartered

Location

Headquarters

HQ city
Chennai
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Pentagrit Discovery business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Contract Research Services: Project-based preclinical research contracts providing zebrafish-based drug discovery, efficacy screening, PK/biodistribution studies, and toxicology assessment services to pharmaceutical and biotech companies

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Pentagrit Discovery product offering

Product offering

Core offering

Pentagrit Discovery is a Contract Research Organization providing zebrafish-based preclinical drug discovery services to pharmaceutical, biotechnology, and agrochemical clients. The company delivers target engagement validation, PK/biodistribution studies, efficacy screening, phenotype rescue behavioral assays, AI-integrated machine interface systems, and a broad disease model library across neuro, metabolic, muscular, rare, eye, inflammation, and tumor indications. Toxicology services cover acute, chronic, reproductive, developmental, behavioral, and organ-specific assessments, with 140+ studies delivered annually on a 60-day standard turnaround.

Product overview

Pentagrit Discovery is a Zebrafish CRO (Contract Research Organization) offering a comprehensive platform of drug discovery services using zebrafish as the primary research model. The company provides an integrated portfolio including Target Engagement (knock-out lines), PK/Biodistribution (DMPK Services), Efficacy Screening, Phenotype Rescue (Behaviour Assays), Agro Discovery, Machine Interface (Zebrafish AI Systems), and characterized Zebrafish Strains. Their discovery platforms cover specific therapeutic areas including MASH, Obesity, NF1, CART, and SSRI screening. The company also maintains extensive disease model libraries spanning Neurodegeneration, Metabolic, Muscular, Rare, Eye, Inflammation, and Tumor categories. Toxicology services include Acute/Chronic, Reproductive, Developmental, Behavioral, and Organ-Specific Toxicity testing. All services leverage zebrafish genetic variants with AI-powered analysis of full functional physiology.

Differentiator

Problem solved

Functional benefit

Products and services

  • Target Engagement (Knock-Out Lines)

Quantifiable outcome

  • 60-day study turnaround time
  • +3 more outcomes

Companies that use Pentagrit Discovery

Customer profile

Segments3 records

Ideal customer profiles3 records

Pentagrit Discovery technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability6 records

Feature6 records

Pentagrit Discovery partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • AD InstrumentscoreTechnology or Integration · 8 February 2026Pentagrit adopted the Powerlab Software System from AD Instruments for real-time data acquisition and analysis in neuronal circuitry research. This integration enhances early discovery services in neurology and deep learning capabilities for AI and technology domains.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Pentagrit Discovery competitors and assessment

Company assessment

Broad incumbents

  • Evotec: Global drug discovery and development CRO with end-to-end preclinical and clinical capabilities. Competes broadly with Pentagrit for outsourced discovery work, though zebrafish is one of many platforms rather than its core focus.
  • WuXi AppTec: Global CRO/CDMO providing preclinical research, DMPK, toxicology, and discovery services. Overlaps with Pentagrit in outsourced preclinical offerings to pharma, at much larger scale and broader service breadth.
  • Inotiv: Preclinical CRO and research models provider with toxicology, safety, and discovery services including alternative model organisms. Competes with Pentagrit for outsourced preclinical work but at significantly larger scale and broader scope.
  • Charles River Laboratories: Large-scale preclinical CRO offering safety assessment, DMPK, and discovery services globally. Broader portfolio than Pentagrit with significant zebrafish and alternative model capabilities, but specializes across many non-zebrafish modalities.
  • Eurofins Scientific: Global life sciences testing CRO offering preclinical, discovery, and central laboratory services. Competes for outsourced preclinical study contracts from pharma, though zebrafish is one of many alternative model offerings.

Direct peers

  • ZeClinics: European zebrafish CRO offering preclinical drug discovery and toxicology services. Directly comparable to Pentagrit in model organism (zebrafish), service mix (efficacy, safety, target validation), and B2B CRO delivery to pharma and biotech clients.
  • Crown Bioscience: Global preclinical CRO with established zebrafish and translational oncology platforms. Comparable in providing zebrafish-based in vivo pharmacology services to pharma and biotech, with broader therapeutic area coverage.
  • Hunter Biotechnology: China-based zebrafish CRO specializing in preclinical drug safety and efficacy evaluation under OECD/GLP standards. Direct competitor to Pentagrit with overlapping zebrafish toxicology and efficacy screening offerings for global pharma sponsors.

Regional players

  • TCG Lifesciences: India-based CRO providing drug discovery and development services across multiple therapeutic areas. Same geographic base as Pentagrit and overlapping preclinical CRO customer segments, with broader integrated discovery-to-development offering.
  • Syngene International: India-headquartered integrated CRO/CDMO offering discovery, development, and manufacturing services. Same geographic base as Pentagrit and overlapping preclinical CRO customer base, though broader therapeutic and modality coverage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights1 record

Customer concentration

Pentagrit Discovery social profiles

Digital presence

Pentagrit Discovery compliance and trust

Trust signal

Compliance2 records

Pentagrit Discovery financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pentagrit Discovery leadership team

Management profile

Number of profiles

Profiles9 records

Pentagrit Discovery funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pentagrit Discovery M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pentagrit Discovery

What does Pentagrit Discovery do?

Pentagrit Discovery is a Contract Research Organization providing zebrafish-based preclinical drug discovery services to pharmaceutical, biotechnology, and agrochemical clients. The company delivers target engagement validation, PK/biodistribution studies, efficacy screening, phenotype rescue behavioral assays, AI-integrated machine interface systems, and a broad disease model library across neuro, metabolic, muscular, rare, eye, inflammation, and tumor indications. Toxicology services cover acute, chronic, reproductive, developmental, behavioral, and organ-specific assessments, with 140+ studies delivered annually on a 60-day standard turnaround.

Is Pentagrit Discovery a public or private company?

Pentagrit Discovery is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Pentagrit Discovery founded?

Pentagrit Discovery was founded in 2011. It employs 11 to 50 people.

Where is Pentagrit Discovery based?

Pentagrit Discovery is headquartered in Chennai, India, in the Asia region.

How does Pentagrit Discovery make money?

One revenue line is on record: contract Research Services.

Who are Pentagrit Discovery's main competitors?

Broad incumbents on record are Evotec, WuXi AppTec, Inotiv, Charles River Laboratories and Eurofins Scientific. Direct peers are ZeClinics, Crown Bioscience and Hunter Biotechnology. Regional players are TCG Lifesciences and Syngene International.

Does Pentagrit Discovery have an API?

No public API is recorded for Pentagrit Discovery.

What industry is Pentagrit Discovery in?

Pentagrit Discovery's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAFAA, In Vivo Pharmacology (Efficacy/PD Models), with a secondary code of HLAAAIAK, In Vivo Discovery & Translational Models Platforms (humanized models, PK/PD, efficacy). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales